Cargando…
ALCAM (CD166) as a gene expression marker for human mesenchymal stromal cell characterisation
BACKGROUND: Human mesenchymal stromal cells (MSCs) phenotypically share their positive expression of the International Society for Cell and Gene Therapy (ISCT) markers CD73, CD90 and CD105 with fibroblasts. Fibroblasts are often co-isolated as an unwanted by-product from biopsy and they can rapidly...
Autores principales: | Brinkhof, Bas, Zhang, Bo, Cui, Zhanfeng, Ye, Hua, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285916/ https://www.ncbi.nlm.nih.gov/pubmed/32550557 http://dx.doi.org/10.1016/j.gene.2020.100031 |
Ejemplares similares
-
ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer
por: Tachezy, Michael, et al.
Publicado: (2012) -
Improving characterisation of human Multipotent Stromal Cells cultured in 2D and 3D: Design and evaluation of primer sets for accurate gene expression normalisation
por: Brinkhof, Bas, et al.
Publicado: (2018) -
Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2015) -
Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer
por: Tan, Fang, et al.
Publicado: (2014) -
ALCAM/CD166 Is Involved in the Binding and Uptake of Cancer-Derived Extracellular Vesicles
por: Cardeñes, Beatriz, et al.
Publicado: (2022)